|
RESEARCH ARTICLE
|
Does Haematological Toxicity Increase with the Use of Lipophilic Chemotherapeutic Agents in Obese Breast Cancer Patients?
Duygu Bayir Garbioglu
doi: 10.14744/ejmi.2023.59404
Pages 1 - 7
(Viewed: 714 / Downloaded: 772)
|
|
Prognostic Significance of C-Reactive Protein and Neutrophil- Lymphocyte Ratio in Lung Adenocarcinoma Patients
Akin Ozturk, Ozlem Oruc, Merve Hormet Igde, Ozgur Bilgin Topcuoglu, Murat Kavas, Cansel Atinkaya Baydemir, Mahmut Gumus
doi: 10.14744/ejmi.2023.42951
Pages 8 - 12
(Viewed: 724 / Downloaded: 787)
|
|
Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways
Elvina Almuradova, Erkan Kahraman, Erdem Goker
doi: 10.14744/ejmi.2023.14963
Pages 13 - 20
(Viewed: 715 / Downloaded: 998)
|
|
Fertility Desire and Protection Practices Among Turkish Young Breast Cancer Patients Treated with Chemotherapy
Kubilay Karaboyun, Eyyup Cavdar, Yakup Irıagac, Seher Yildiz Tacar, Okan Avci, Selcuk Seber
doi: 10.14744/ejmi.2023.97379
Pages 21 - 27
(Viewed: 590 / Downloaded: 777)
|
|
Combined LDH Albumin Score (CLAS) and Neutrophil Lymphocyte Ratio (NLR) are Predictive for Survival Patients with Metastatic Non-Small Cell Carcinoma Treated with Nivolumab as Monotherapy
Elif Sahin
doi: 10.14744/ejmi.2023.21564
Pages 28 - 34
(Viewed: 565 / Downloaded: 973)
|
|
Evaluation of Craniovertebral Junction Anatomy by Gender and Age in the Anatolian Population
Asrin Nalbant, Ozden Bedre Duygu, Halide Temelci, Zulal Oner, Serkan Oner
doi: 10.14744/ejmi.2023.47873
Pages 35 - 42
(Viewed: 703 / Downloaded: 707)
|
|
Rechallenge Immunotherapy in Former Interferon-Treated Patients with Metastatic Renal Cell Carcinoma
Elvina Almuradova, Cemre Engin, Rashad Ismayilov
doi: 10.14744/ejmi.2023.11907
Pages 43 - 47
(Viewed: 600 / Downloaded: 918)
|
|
Comparison of the Efficacy of Dual Chemotherapy Regimens in Second-Line Treatment of Metastatic Esophageal Squamous Cell Carcinoma
Gurkan Guner, Yasin Sezgin
doi: 10.14744/ejmi.2023.20180
Pages 48 - 53
(Viewed: 547 / Downloaded: 798)
|
|
Can Pan-Immune Inflammation Value and Systemic Inflammatory Response Index be Used Clinically to Predict Inflammation in Patients with Non-Small Cell Lung Cancer?
Selen Karaoglanoglu, Huseyin Erdal, Muge Karaoglanoglu Sonmez
doi: 10.14744/ejmi.2023.39651
Pages 54 - 57
(Viewed: 648 / Downloaded: 802)
|
|
The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer
Ozlem Ozkul, Elif Sahin, Devrim Cabuk, Nadiye Sever, Nargiz Majidova, İbrahim Vedat Bayoglu
doi: 10.14744/ejmi.2023.36214
Pages 58 - 66
(Viewed: 539 / Downloaded: 995)
|
|
Evaluation of PIV Score as a Predictor Biomarker for Pathologically Proven Intermediate-High Risk Gastric Gastrointestinal Stromal Tumors
Oktay Unsal, Ahmet Ozet
doi: 10.14744/ejmi.2023.70078
Pages 67 - 72
(Viewed: 743 / Downloaded: 778)
|
|
Effects of a Multidisciplinary Therapeutic Approach to ''Diabetic Foot'' Complications: A Single-Center Pilot Study from Turkey
Necdet Demir
doi: 10.14744/ejmi.2023.97821
Pages 73 - 78
(Viewed: 652 / Downloaded: 815)
|
|
Fever of Unknown Origin: A Diagnostic Pitfall
Mustafa Altinkaynak, Yavuz Burak Tor
doi: 10.14744/ejmi.2024.74277
Pages 79 - 84
(Viewed: 98 / Downloaded: 219)
|
|
